Life Technologies Corp. v. Promega Corp.

On February 22, 2017, the Supreme Court issued its decision in Life Technologies Corp. v. Promega Corp.1, a case focused on interpreting the patent infringement statute which creates liability for exporting a component of a patented invention.  Specifically, the Court considered whether a single component may be “a substantial portion of the components of a patented invention.”2  Reversing the Federal Circuit’s decision, the Supreme Court held that the “supply of a single component of a multicomponent invention for manufacture abroad does not give rise to §271(f)(1) liability.”3

To view the entire article please go here.